Cargando…
Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma
In renal-cell carcinoma (RCC), tumor-reactive T-cell responses can occur spontaneously or in response to systemic immunotherapy with cytokines and immune checkpoint inhibitors. Cancer vaccines and engineered T-cell therapies are designed to selectively augment tumor antigen-specific CD8(+) T-cell re...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189101/ https://www.ncbi.nlm.nih.gov/pubmed/33667140 http://dx.doi.org/10.1080/21645515.2020.1870846 |